Anne Libby
Concepts (362)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicaid | 12 | 2024 | 433 | 1.630 |
Why?
| | Mental Health Services | 12 | 2016 | 409 | 1.560 |
Why?
| | Financing, Organized | 4 | 2020 | 35 | 1.310 |
Why?
| | Research Personnel | 5 | 2020 | 168 | 1.150 |
Why?
| | Comparative Effectiveness Research | 4 | 2013 | 152 | 1.050 |
Why?
| | Depressive Disorder, Major | 5 | 2009 | 361 | 0.910 |
Why?
| | Indians, North American | 6 | 2008 | 624 | 0.880 |
Why?
| | Nonprescription Drugs | 3 | 2016 | 66 | 0.870 |
Why?
| | Substance-Related Disorders | 8 | 2008 | 1079 | 0.840 |
Why?
| | Biomedical Research | 5 | 2020 | 688 | 0.820 |
Why?
| | Antidepressive Agents | 6 | 2015 | 239 | 0.800 |
Why?
| | Managed Care Programs | 10 | 2011 | 129 | 0.790 |
Why?
| | Sex Factors | 8 | 2025 | 2067 | 0.750 |
Why?
| | Depressive Disorder | 6 | 2015 | 383 | 0.720 |
Why?
| | Faculty, Medical | 4 | 2022 | 283 | 0.720 |
Why?
| | Mentoring | 3 | 2022 | 144 | 0.710 |
Why?
| | Capitation Fee | 5 | 2002 | 14 | 0.670 |
Why?
| | Interdisciplinary Research | 1 | 2020 | 27 | 0.670 |
Why?
| | Mental Disorders | 5 | 2017 | 1080 | 0.640 |
Why?
| | Sex Characteristics | 3 | 2022 | 766 | 0.610 |
Why?
| | Antihypertensive Agents | 4 | 2025 | 493 | 0.590 |
Why?
| | United States Food and Drug Administration | 4 | 2009 | 208 | 0.570 |
Why?
| | Emergency Services, Psychiatric | 1 | 2017 | 31 | 0.550 |
Why?
| | Pharmacists | 2 | 2024 | 258 | 0.550 |
Why?
| | Child Welfare | 4 | 2007 | 218 | 0.550 |
Why?
| | Academic Medical Centers | 3 | 2020 | 494 | 0.530 |
Why?
| | Interdisciplinary Studies | 1 | 2016 | 27 | 0.530 |
Why?
| | Writing | 1 | 2018 | 94 | 0.520 |
Why?
| | Prescription Drugs | 2 | 2016 | 110 | 0.510 |
Why?
| | Mentors | 5 | 2022 | 192 | 0.500 |
Why?
| | Academies and Institutes | 1 | 2016 | 54 | 0.500 |
Why?
| | Child Abuse | 6 | 2008 | 542 | 0.490 |
Why?
| | United States | 31 | 2025 | 14595 | 0.490 |
Why?
| | Science | 1 | 2016 | 53 | 0.480 |
Why?
| | Contract Services | 3 | 2002 | 10 | 0.480 |
Why?
| | Fee-for-Service Plans | 5 | 2002 | 85 | 0.470 |
Why?
| | Colorado | 17 | 2020 | 4491 | 0.450 |
Why?
| | Health Policy | 5 | 2016 | 388 | 0.450 |
Why?
| | Quality-Adjusted Life Years | 3 | 2014 | 111 | 0.450 |
Why?
| | Child Abuse, Sexual | 3 | 2007 | 90 | 0.440 |
Why?
| | Health Care Costs | 2 | 2010 | 386 | 0.440 |
Why?
| | Juvenile Delinquency | 3 | 2004 | 109 | 0.440 |
Why?
| | Dibenzothiazepines | 1 | 2013 | 17 | 0.430 |
Why?
| | Cooperative Behavior | 1 | 2016 | 445 | 0.420 |
Why?
| | Humans | 77 | 2025 | 136898 | 0.420 |
Why?
| | Medication Therapy Management | 1 | 2014 | 75 | 0.420 |
Why?
| | Telemedicine | 2 | 2024 | 843 | 0.410 |
Why?
| | Data Collection | 5 | 2012 | 674 | 0.410 |
Why?
| | Length of Stay | 2 | 2017 | 1203 | 0.410 |
Why?
| | Adolescent | 33 | 2017 | 21402 | 0.400 |
Why?
| | Videoconferencing | 2 | 2017 | 66 | 0.400 |
Why?
| | Cohort Studies | 13 | 2016 | 5711 | 0.390 |
Why?
| | Suicide, Attempted | 3 | 2015 | 372 | 0.390 |
Why?
| | Female | 50 | 2025 | 72703 | 0.380 |
Why?
| | Physicians | 4 | 2022 | 902 | 0.380 |
Why?
| | Male | 47 | 2025 | 67308 | 0.370 |
Why?
| | Antipsychotic Agents | 1 | 2013 | 196 | 0.370 |
Why?
| | Cities | 1 | 2012 | 132 | 0.370 |
Why?
| | Income | 1 | 2012 | 201 | 0.360 |
Why?
| | Unemployment | 1 | 2010 | 44 | 0.350 |
Why?
| | Practice Patterns, Physicians' | 5 | 2025 | 1310 | 0.340 |
Why?
| | Cost of Illness | 1 | 2012 | 302 | 0.330 |
Why?
| | Plant Preparations | 1 | 2010 | 34 | 0.330 |
Why?
| | Depression | 3 | 2014 | 1402 | 0.320 |
Why?
| | Research Support as Topic | 3 | 2020 | 118 | 0.320 |
Why?
| | Cost-Benefit Analysis | 6 | 2017 | 592 | 0.310 |
Why?
| | Polypharmacy | 2 | 2024 | 83 | 0.310 |
Why?
| | Prescriptions | 1 | 2009 | 67 | 0.310 |
Why?
| | Cross-Sectional Studies | 9 | 2025 | 5398 | 0.300 |
Why?
| | Tobacco Smoke Pollution | 1 | 2012 | 284 | 0.300 |
Why?
| | Middle Aged | 29 | 2025 | 33118 | 0.300 |
Why?
| | Child, Preschool | 14 | 2017 | 11013 | 0.300 |
Why?
| | Multivariate Analysis | 6 | 2017 | 1524 | 0.300 |
Why?
| | Epilepsy | 1 | 2012 | 334 | 0.290 |
Why?
| | Hypertension | 3 | 2025 | 1291 | 0.290 |
Why?
| | Point-of-Care Systems | 1 | 2010 | 163 | 0.290 |
Why?
| | Premature Birth | 1 | 2012 | 331 | 0.290 |
Why?
| | Health Maintenance Organizations | 2 | 2005 | 97 | 0.290 |
Why?
| | Child | 24 | 2017 | 21896 | 0.280 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2007 | 843 | 0.280 |
Why?
| | Chronic Disease | 2 | 2013 | 1773 | 0.280 |
Why?
| | Health Services Accessibility | 3 | 2007 | 964 | 0.280 |
Why?
| | Drug and Narcotic Control | 1 | 2007 | 28 | 0.270 |
Why?
| | Combat Disorders | 1 | 2007 | 37 | 0.270 |
Why?
| | Interview, Psychological | 1 | 2007 | 98 | 0.270 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2009 | 179 | 0.270 |
Why?
| | Research Design | 3 | 2019 | 1108 | 0.260 |
Why?
| | Parents | 3 | 2017 | 1361 | 0.260 |
Why?
| | Education, Medical | 2 | 2020 | 260 | 0.260 |
Why?
| | Health Behavior | 1 | 2012 | 761 | 0.250 |
Why?
| | Longitudinal Studies | 8 | 2016 | 2844 | 0.250 |
Why?
| | Adult | 26 | 2025 | 37595 | 0.250 |
Why?
| | Diabetes Mellitus | 2 | 2014 | 1033 | 0.240 |
Why?
| | Decision Making | 1 | 2013 | 897 | 0.240 |
Why?
| | Retrospective Studies | 13 | 2025 | 15514 | 0.240 |
Why?
| | Aged | 20 | 2025 | 23641 | 0.240 |
Why?
| | Hypoglycemia | 1 | 2010 | 442 | 0.240 |
Why?
| | Aged, 80 and over | 9 | 2024 | 7552 | 0.230 |
Why?
| | Rural Population | 2 | 2007 | 561 | 0.230 |
Why?
| | Ambulatory Care | 4 | 2014 | 528 | 0.230 |
Why?
| | Family | 2 | 2006 | 667 | 0.230 |
Why?
| | Stress, Psychological | 2 | 2010 | 1112 | 0.220 |
Why?
| | Curriculum | 3 | 2020 | 978 | 0.220 |
Why?
| | Parenting | 1 | 2008 | 311 | 0.220 |
Why?
| | Smoking | 1 | 2012 | 1633 | 0.220 |
Why?
| | Crime | 1 | 2004 | 60 | 0.220 |
Why?
| | Suicide | 3 | 2007 | 646 | 0.210 |
Why?
| | Deprescriptions | 1 | 2024 | 35 | 0.210 |
Why?
| | Electronic Health Records | 3 | 2015 | 1018 | 0.190 |
Why?
| | Residential Treatment | 1 | 2002 | 30 | 0.190 |
Why?
| | Primary Health Care | 4 | 2024 | 1741 | 0.190 |
Why?
| | Foster Home Care | 1 | 2003 | 81 | 0.190 |
Why?
| | Adolescent Psychiatry | 1 | 2002 | 13 | 0.190 |
Why?
| | Infant | 9 | 2017 | 9408 | 0.190 |
Why?
| | Brain Injuries | 2 | 2005 | 489 | 0.190 |
Why?
| | Contracts | 1 | 2001 | 12 | 0.180 |
Why?
| | Logistic Models | 6 | 2017 | 2060 | 0.180 |
Why?
| | Criminal Law | 1 | 2002 | 31 | 0.180 |
Why?
| | Anxiety Disorders | 1 | 2005 | 376 | 0.180 |
Why?
| | Child Psychiatry | 1 | 2002 | 35 | 0.180 |
Why?
| | Costs and Cost Analysis | 3 | 2010 | 207 | 0.180 |
Why?
| | Schizophrenia | 1 | 2005 | 446 | 0.180 |
Why?
| | Health Surveys | 3 | 2010 | 520 | 0.180 |
Why?
| | Blood Pressure | 2 | 2025 | 1774 | 0.180 |
Why?
| | Hypoglycemic Agents | 1 | 2010 | 1282 | 0.180 |
Why?
| | Hospitals, Pediatric | 2 | 2017 | 533 | 0.170 |
Why?
| | Surface Plasmon Resonance | 1 | 2021 | 88 | 0.170 |
Why?
| | Severity of Illness Index | 6 | 2014 | 2833 | 0.170 |
Why?
| | Dementia | 1 | 2024 | 252 | 0.170 |
Why?
| | Organizational Innovation | 2 | 2020 | 139 | 0.170 |
Why?
| | Dried Blood Spot Testing | 1 | 2021 | 103 | 0.170 |
Why?
| | Caregivers | 3 | 2024 | 865 | 0.170 |
Why?
| | Women's Health | 2 | 2020 | 371 | 0.160 |
Why?
| | Organophosphates | 1 | 2021 | 133 | 0.160 |
Why?
| | Young Adult | 10 | 2017 | 13157 | 0.160 |
Why?
| | Education | 1 | 2020 | 108 | 0.160 |
Why?
| | Population Groups | 3 | 2017 | 63 | 0.160 |
Why?
| | Interdisciplinary Communication | 1 | 2020 | 192 | 0.150 |
Why?
| | Adenine | 1 | 2021 | 267 | 0.150 |
Why?
| | Healthcare Disparities | 1 | 2025 | 632 | 0.150 |
Why?
| | Health Services Research | 3 | 2016 | 403 | 0.150 |
Why?
| | Foundations | 1 | 2018 | 28 | 0.140 |
Why?
| | Suicidal Ideation | 2 | 2015 | 522 | 0.140 |
Why?
| | Gender Identity | 1 | 2019 | 124 | 0.140 |
Why?
| | Program Evaluation | 5 | 2021 | 889 | 0.140 |
Why?
| | Chi-Square Distribution | 3 | 2012 | 533 | 0.140 |
Why?
| | Hospital Costs | 2 | 2012 | 119 | 0.140 |
Why?
| | Hospitalization | 2 | 2011 | 2183 | 0.140 |
Why?
| | Sexism | 1 | 2018 | 62 | 0.140 |
Why?
| | Program Development | 1 | 2019 | 366 | 0.140 |
Why?
| | Attitude to Health | 2 | 2017 | 444 | 0.140 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2013 | 2066 | 0.130 |
Why?
| | Public Health Administration | 1 | 1997 | 75 | 0.130 |
Why?
| | Leadership | 1 | 2020 | 376 | 0.120 |
Why?
| | Reminder Systems | 1 | 2017 | 176 | 0.120 |
Why?
| | Veterans | 1 | 2007 | 1446 | 0.120 |
Why?
| | Risk Factors | 8 | 2012 | 10313 | 0.120 |
Why?
| | Immunization | 1 | 2017 | 414 | 0.120 |
Why?
| | Alcoholism | 1 | 2002 | 798 | 0.120 |
Why?
| | Florida | 2 | 2025 | 101 | 0.110 |
Why?
| | Accidents | 2 | 2005 | 39 | 0.110 |
Why?
| | Community Mental Health Services | 2 | 2007 | 87 | 0.110 |
Why?
| | Comorbidity | 3 | 2015 | 1611 | 0.110 |
Why?
| | Quetiapine Fumarate | 1 | 2013 | 23 | 0.110 |
Why?
| | Oregon | 1 | 2013 | 72 | 0.110 |
Why?
| | Health Information Management | 1 | 2013 | 7 | 0.100 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 434 | 0.100 |
Why?
| | Patient Satisfaction | 1 | 2017 | 657 | 0.100 |
Why?
| | Decision Support Techniques | 2 | 2014 | 413 | 0.100 |
Why?
| | Health Expenditures | 2 | 2006 | 185 | 0.100 |
Why?
| | Alcohol-Related Disorders | 2 | 2005 | 124 | 0.100 |
Why?
| | Interviews as Topic | 2 | 2020 | 759 | 0.100 |
Why?
| | Minority Groups | 2 | 2022 | 269 | 0.100 |
Why?
| | Medical Audit | 1 | 2013 | 76 | 0.100 |
Why?
| | Age Factors | 5 | 2012 | 3290 | 0.100 |
Why?
| | Medical Records Systems, Computerized | 1 | 2013 | 93 | 0.100 |
Why?
| | Women's Health Services | 2 | 2006 | 16 | 0.100 |
Why?
| | Analysis of Variance | 2 | 2014 | 1324 | 0.100 |
Why?
| | Regression Analysis | 3 | 2011 | 1026 | 0.100 |
Why?
| | Economics, Pharmaceutical | 1 | 2012 | 9 | 0.100 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 744 | 0.100 |
Why?
| | Education, Pharmacy, Graduate | 1 | 2012 | 17 | 0.100 |
Why?
| | Efficiency | 1 | 2012 | 98 | 0.100 |
Why?
| | Diagnostic Tests, Routine | 1 | 2013 | 109 | 0.090 |
Why?
| | Pilot Projects | 2 | 2024 | 1684 | 0.090 |
Why?
| | Education, Graduate | 1 | 2012 | 34 | 0.090 |
Why?
| | Prevalence | 3 | 2011 | 2709 | 0.090 |
Why?
| | Health Services | 1 | 2012 | 103 | 0.090 |
Why?
| | Referral and Consultation | 1 | 2017 | 779 | 0.090 |
Why?
| | Maternal Age | 1 | 2012 | 130 | 0.090 |
Why?
| | Self Care | 1 | 2014 | 374 | 0.090 |
Why?
| | Advisory Committees | 3 | 2007 | 220 | 0.090 |
Why?
| | Hospitals, University | 1 | 2012 | 181 | 0.090 |
Why?
| | Patient-Centered Care | 1 | 2016 | 523 | 0.090 |
Why?
| | State Health Plans | 2 | 2002 | 30 | 0.090 |
Why?
| | Infant, Small for Gestational Age | 1 | 2012 | 88 | 0.090 |
Why?
| | Nausea | 1 | 2011 | 115 | 0.090 |
Why?
| | Psychomotor Agitation | 1 | 2011 | 70 | 0.090 |
Why?
| | Interinstitutional Relations | 1 | 2011 | 54 | 0.090 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2012 | 97 | 0.090 |
Why?
| | Sexual Dysfunction, Physiological | 1 | 2011 | 65 | 0.090 |
Why?
| | Vomiting | 1 | 2011 | 133 | 0.090 |
Why?
| | Radiography, Interventional | 1 | 2012 | 114 | 0.090 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2012 | 91 | 0.090 |
Why?
| | Medicare | 3 | 2024 | 745 | 0.090 |
Why?
| | Employment | 1 | 2012 | 177 | 0.090 |
Why?
| | Drug Labeling | 2 | 2007 | 40 | 0.090 |
Why?
| | Policy Making | 1 | 2011 | 98 | 0.090 |
Why?
| | Headache | 1 | 2011 | 154 | 0.090 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2011 | 103 | 0.080 |
Why?
| | Computer Communication Networks | 1 | 2010 | 33 | 0.080 |
Why?
| | Social Support | 2 | 2020 | 614 | 0.080 |
Why?
| | Medication Adherence | 1 | 2014 | 514 | 0.080 |
Why?
| | Heart Transplantation | 1 | 2016 | 746 | 0.080 |
Why?
| | Proportional Hazards Models | 3 | 2015 | 1262 | 0.080 |
Why?
| | Influenza, Human | 2 | 2017 | 626 | 0.080 |
Why?
| | California | 3 | 2007 | 423 | 0.080 |
Why?
| | Life Style | 1 | 2012 | 480 | 0.080 |
Why?
| | Drug Utilization Review | 1 | 2009 | 56 | 0.080 |
Why?
| | Vaccination | 1 | 2017 | 1387 | 0.080 |
Why?
| | Financing, Government | 2 | 2000 | 46 | 0.080 |
Why?
| | Information Dissemination | 1 | 2011 | 218 | 0.080 |
Why?
| | Residence Characteristics | 1 | 2012 | 350 | 0.080 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2012 | 359 | 0.070 |
Why?
| | Drug Prescriptions | 2 | 2007 | 250 | 0.070 |
Why?
| | Community-Institutional Relations | 1 | 2009 | 99 | 0.070 |
Why?
| | Surveys and Questionnaires | 4 | 2020 | 5730 | 0.070 |
Why?
| | Catheter Ablation | 1 | 2012 | 348 | 0.070 |
Why?
| | HIV Infections | 2 | 2021 | 2822 | 0.070 |
Why?
| | Absorptiometry, Photon | 1 | 2009 | 251 | 0.070 |
Why?
| | Prospective Studies | 3 | 2021 | 7543 | 0.070 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2007 | 46 | 0.070 |
Why?
| | Office Visits | 1 | 2007 | 91 | 0.070 |
Why?
| | Drug Administration Schedule | 1 | 2009 | 784 | 0.070 |
Why?
| | Trauma Severity Indices | 2 | 2005 | 106 | 0.070 |
Why?
| | Databases, Factual | 4 | 2016 | 1345 | 0.060 |
Why?
| | Drug Utilization | 1 | 2007 | 170 | 0.060 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 243 | 0.060 |
Why?
| | Infant, Newborn | 4 | 2012 | 6043 | 0.060 |
Why?
| | Diagnosis, Dual (Psychiatry) | 1 | 2005 | 36 | 0.060 |
Why?
| | Physicians, Family | 1 | 2007 | 206 | 0.060 |
Why?
| | Liver Neoplasms | 1 | 2012 | 783 | 0.060 |
Why?
| | Sleep | 1 | 2011 | 751 | 0.060 |
Why?
| | Cost Savings | 2 | 2012 | 83 | 0.060 |
Why?
| | Parent-Child Relations | 1 | 2008 | 272 | 0.060 |
Why?
| | Alcohol Drinking | 1 | 2012 | 823 | 0.060 |
Why?
| | Bone Density | 1 | 2009 | 486 | 0.060 |
Why?
| | Pregnancy | 2 | 2020 | 6715 | 0.060 |
Why?
| | Psychiatry | 1 | 2007 | 181 | 0.060 |
Why?
| | Northwestern United States | 1 | 2004 | 55 | 0.050 |
Why?
| | Southwestern United States | 1 | 2004 | 90 | 0.050 |
Why?
| | Brain Damage, Chronic | 1 | 2003 | 20 | 0.050 |
Why?
| | Direct Service Costs | 1 | 2003 | 10 | 0.050 |
Why?
| | Age of Onset | 1 | 2005 | 520 | 0.050 |
Why?
| | Volition | 1 | 2003 | 34 | 0.050 |
Why?
| | Quality of Life | 1 | 2015 | 2847 | 0.050 |
Why?
| | Odds Ratio | 2 | 2004 | 1063 | 0.050 |
Why?
| | Monte Carlo Method | 2 | 2014 | 145 | 0.050 |
Why?
| | Tobacco Use Disorder | 1 | 2005 | 252 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2013 | 10768 | 0.050 |
Why?
| | Sampling Studies | 1 | 2003 | 100 | 0.050 |
Why?
| | Somatoform Disorders | 1 | 2003 | 42 | 0.050 |
Why?
| | Physician-Patient Relations | 1 | 2007 | 552 | 0.050 |
Why?
| | Marijuana Abuse | 1 | 2005 | 234 | 0.050 |
Why?
| | Rehabilitation, Vocational | 1 | 2002 | 2 | 0.050 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2022 | 92 | 0.050 |
Why?
| | Cost Allocation | 1 | 2002 | 7 | 0.050 |
Why?
| | Factor Analysis, Statistical | 1 | 2003 | 287 | 0.050 |
Why?
| | Child Health Services | 2 | 2001 | 185 | 0.050 |
Why?
| | Calcium Channel Blockers | 1 | 2022 | 168 | 0.050 |
Why?
| | Qualitative Research | 2 | 2020 | 1335 | 0.050 |
Why?
| | Reimbursement, Incentive | 1 | 2002 | 37 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2009 | 3528 | 0.050 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 202 | 0.050 |
Why?
| | Emergency Medical Services | 1 | 2007 | 545 | 0.050 |
Why?
| | Immunity | 1 | 2022 | 145 | 0.040 |
Why?
| | Practice Management, Medical | 1 | 2001 | 36 | 0.040 |
Why?
| | Data Interpretation, Statistical | 1 | 2003 | 352 | 0.040 |
Why?
| | Confidence Intervals | 1 | 2002 | 328 | 0.040 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2022 | 324 | 0.040 |
Why?
| | Occupational Diseases | 1 | 2002 | 157 | 0.040 |
Why?
| | Adolescent Behavior | 1 | 2005 | 536 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2024 | 943 | 0.040 |
Why?
| | International Classification of Diseases | 2 | 2015 | 131 | 0.040 |
Why?
| | Incidence | 2 | 2005 | 2783 | 0.040 |
Why?
| | Pediatrics | 1 | 2007 | 1119 | 0.040 |
Why?
| | Models, Statistical | 1 | 2003 | 667 | 0.040 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 1999 | 83 | 0.040 |
Why?
| | Health Care Surveys | 2 | 1997 | 565 | 0.040 |
Why?
| | Social Stigma | 1 | 2020 | 132 | 0.040 |
Why?
| | Risk Assessment | 3 | 2015 | 3432 | 0.040 |
Why?
| | Career Choice | 1 | 2019 | 215 | 0.030 |
Why?
| | Competitive Bidding | 1 | 1997 | 3 | 0.030 |
Why?
| | Administrative Personnel | 1 | 1997 | 30 | 0.030 |
Why?
| | Decision Making, Organizational | 1 | 1997 | 29 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3697 | 0.030 |
Why?
| | Specialization | 2 | 2007 | 143 | 0.030 |
Why?
| | Pneumococcal Infections | 1 | 2017 | 116 | 0.030 |
Why?
| | Pneumococcal Vaccines | 1 | 2017 | 145 | 0.030 |
Why?
| | Motivation | 1 | 2001 | 570 | 0.030 |
Why?
| | National Institute of Mental Health (U.S.) | 1 | 2016 | 5 | 0.030 |
Why?
| | Models, Organizational | 1 | 1997 | 146 | 0.030 |
Why?
| | Citalopram | 1 | 2015 | 32 | 0.030 |
Why?
| | Medicine | 2 | 2007 | 120 | 0.030 |
Why?
| | Immunization Programs | 1 | 2017 | 219 | 0.030 |
Why?
| | Fluoxetine | 1 | 2015 | 54 | 0.030 |
Why?
| | Focus Groups | 1 | 2017 | 500 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2016 | 268 | 0.030 |
Why?
| | Treatment Failure | 1 | 2015 | 353 | 0.030 |
Why?
| | Uncertainty | 1 | 2014 | 125 | 0.030 |
Why?
| | Urban Population | 1 | 1997 | 470 | 0.030 |
Why?
| | Probability | 1 | 2014 | 311 | 0.030 |
Why?
| | Reoperation | 1 | 2016 | 568 | 0.030 |
Why?
| | American Recovery and Reinvestment Act | 1 | 2013 | 6 | 0.030 |
Why?
| | Insurance Claim Review | 1 | 2013 | 63 | 0.030 |
Why?
| | Influenza Vaccines | 1 | 2017 | 545 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1060 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 850 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2014 | 226 | 0.020 |
Why?
| | Schools, Pharmacy | 1 | 2012 | 47 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 1999 | 934 | 0.020 |
Why?
| | Databases as Topic | 1 | 2011 | 66 | 0.020 |
Why?
| | Decision Trees | 1 | 2012 | 94 | 0.020 |
Why?
| | Models, Economic | 1 | 2012 | 57 | 0.020 |
Why?
| | Faculty | 1 | 2012 | 143 | 0.020 |
Why?
| | Radiotherapy | 1 | 2012 | 201 | 0.020 |
Why?
| | Health Care Rationing | 1 | 2011 | 60 | 0.020 |
Why?
| | Propensity Score | 1 | 2011 | 287 | 0.020 |
Why?
| | Patient Discharge | 1 | 2016 | 887 | 0.020 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2011 | 148 | 0.020 |
Why?
| | Legislation, Medical | 1 | 2007 | 11 | 0.020 |
Why?
| | Poverty Areas | 1 | 2007 | 39 | 0.020 |
Why?
| | Crisis Intervention | 1 | 2007 | 33 | 0.020 |
Why?
| | Computer Simulation | 1 | 2012 | 984 | 0.020 |
Why?
| | Appointments and Schedules | 1 | 2007 | 89 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 1999 | 2243 | 0.020 |
Why?
| | Students | 1 | 2012 | 625 | 0.020 |
Why?
| | Least-Squares Analysis | 1 | 2006 | 79 | 0.020 |
Why?
| | Drug Monitoring | 1 | 2007 | 221 | 0.020 |
Why?
| | Ontario | 1 | 2006 | 156 | 0.020 |
Why?
| | Osteoporosis | 1 | 2009 | 241 | 0.020 |
Why?
| | Time Factors | 1 | 2016 | 6802 | 0.020 |
Why?
| | Health Status Indicators | 1 | 2006 | 171 | 0.010 |
Why?
| | Seasons | 1 | 2007 | 540 | 0.010 |
Why?
| | Pandemics | 1 | 2011 | 1615 | 0.010 |
Why?
| | Physician Incentive Plans | 1 | 2000 | 7 | 0.010 |
Why?
| | Cost Control | 1 | 2000 | 39 | 0.010 |
Why?
| | Multicenter Studies as Topic | 1 | 2002 | 303 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2005 | 901 | 0.010 |
Why?
| | Adolescent Health Services | 1 | 2001 | 75 | 0.010 |
Why?
| | Workplace | 1 | 2002 | 261 | 0.010 |
Why?
| | Health Care Reform | 1 | 2000 | 102 | 0.010 |
Why?
| | Primary Prevention | 1 | 2000 | 195 | 0.010 |
Why?
| | Interpersonal Relations | 1 | 2002 | 410 | 0.010 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 1999 | 80 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2007 | 5126 | 0.010 |
Why?
| | Quality Indicators, Health Care | 1 | 2000 | 310 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 1999 | 349 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 1999 | 690 | 0.010 |
Why?
| | Patient Care Team | 1 | 2002 | 624 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2002 | 1460 | 0.010 |
Why?
| | Prognosis | 1 | 1999 | 4011 | 0.010 |
Why?
|
|
Libby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|